Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study (May, 10.1007/s13311-022-01237-4, 2022)Michael Benatar,Joanne Wuu,Peter M. Andersen,Robert C. Bucelli,Jinsy A. Andrews,Markus Otto,Nita A. Farahany,Elizabeth A. Harrington, Weiping Chen,Adele A. Mitchell,Toby Ferguson,Sheena Chew,Liz Gedney,Sue Oakley,Jeong Heo,Sowmya Chary,Laura Fanning,Danielle Graham,Peng Sun,Yingying Liu,Janice Wong,Stephanie FradetteNEUROTHERAPEUTICS（2022）引用 19|浏览20AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
